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Small-angle X-ray scattering (SAXS) has been proven to be apowerful technique to investigate the structure of soft
matter and biological macromolecules at the nanometer-
scale.1,2 It has demonstrated its potential for diverse
applications, from nucleation studies (i.e., glycine crystals3 or
colloidal silica4) to the determination of proteins molecular
weight,6 or to study protein interactions in solution prior to
crystallization,5 protein structure,7 or even conformational
changes.8 SAXS measurements have also been used to
determine the second virial coeﬃcient, A2 a thermodynamic
parameter characterizing protein interaction which has been
proved to be a powerful tool to predict crystallization
conditions and therefore protein solubility.
However, the required volume for each measurement,
together with the large number of experiments necessary to
obtain reliable statistical information at each studied condition,
makes this technique less convenient when working with high
value compounds. To partially solve this issue, few studies are
reported in literature proposing the coupling of single-phase
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ABSTRACT: In this work, we propose the combination of small-angle X-ray scattering (SAXS) and high throughput, droplet 
based microﬂuidics as a powerful tool to investigate macromolecular interactions, directly related to protein solubility. For this 
purpose, a robust and low cost microﬂuidic platform was fabricated for achieving the mixing of proteins, crystallization reagents, 
and buﬀer in nanoliter volumes and the subsequent generation of nanodroplets by means of a two phase ﬂow. The protein 
samples are compartmentalized inside droplets, each one acting as an isolated microreactor. Hence their physicochemical 
conditions (concentration, pH, etc.) can be ﬁnely tuned without cross-contamination, allowing the screening of a huge number of 
saturation conditions with a small amount of biological material. The droplet ﬂow is synchronized with synchrotron radiation 
SAXS measurements to probe protein interactions while minimizing radiation damage. To this end, the experimental setup was 
tested with rasburicase (known to be very sensitive to denaturation), proving the structural stability of the protein in the droplets 
and the absence of radiation damage. Subsequently weak interaction variations as a function of protein saturation was studied for 
the model protein lysozime. The second virial coeﬃcients (A2) were determined from the X-ray structure factors extrapolated to 
the origin. A2 obtained values were found to be in good agreement with data previously reported in literature but using only a 
few milligrams of protein. The experimental results presented here highlight the interest and convenience of using this 
methodology as a promising and potential candidate for studying protein interactions for the construction of phase diagrams.
continuous ﬂow microﬂuidics and SAXS in order to screen
phase behaviors,9 to study self-assembly of surfactants10 or
biological macromolecules,11 or also to investigate nucleation
and growth of gold nanoparticles.12 However, this approach
presents a major drawback: a continuous ﬂow can be
unfavorable when ﬂuids modify their characteristics after
being mixed, as components are able to diﬀuse in the channels
and, in the case of crystallization studies, a nucleating phase can
inhibit the precipitation and growth of other diﬀerent phases. In
this sense, the use of droplet-based microﬂuidics seems more
convenient. A dispersed phase can be created by mixing several
miscible compounds and subsequently periodically separated by
a continuous phase, generating monodisperse droplets, which
are suspended in an external carrier phase thus behaving as
isolated microreactors, as the immiscibility of the two phases
prevents diﬀusion from one droplet to another. With this
technique hundreds/thousands of independent experiments
can be generated with ease in a short period of time and using a
very low quantity of reagents. Droplet microﬂuidics has already
been extensively used for studying nucleation and crystal
growth of proteins,13−15 membrane proteins,16 nucleation of
inorganic salts,17,18 or drug molecules.19 So far, the promising
combination of continuous ﬂow droplet-based microﬂuidics
and SAXS has been sparsely reported for very few and diﬀerent
approaches in the literature dealing with gold nanoparticles20
and liquid crystals.21
In this paper, we demonstrate the convenience of combining
high throughput droplet-based microﬂuidics and SAXS for the
study of protein crystallization process, from undersaturation to
supersaturation and phase transition, focusing on the study of
weak interactions in solution.
A low cost microﬂuidic platform is fabricated to generate
monodisperse aqueous droplets containing proteins, buﬀer, and
crystallization agent dispersed in an external oil phase
containing a nonionic surfactant to stabilize the interface of
the droplets without interacting with the molecules in solution.
Generated droplets are carried through the X-ray beam to
record SAXS data for hundreds of experiments using just a few
mg of protein and automatically screen a huge amount of
crystallization conditions. From the nanometer-scale informa-
tion on the structure and the shape of proteins in solution the
second virial coeﬃcients, A2, have been obtained for diﬀerent
saturation conditions. These A2 values, relevant parameters for
the prediction of protein solubility, were found to be in
agreement with previous values reported in the literature,
therefore validating the methodology here proposed.
■ MATERIALS AND METHODS
Microﬂuidic Setup. Microﬂuidic Chip Fabrication. Micro-
ﬂuidic droplet generation platforms, with rectangular channels
with a cross section of 200 × 200 μm2, were fabricated using
standard soft lithography and cast molding techniques. An
inexpensive multilevel negative tone photoresist dry ﬁlm
(WBR2000 series, DuPont, France) was laminated on a glass
substrate (Thermo Scientiﬁc Menzel-Glaser, Germany) follow-
ing the procedure described in Figure S1 and Table S1 of the
Supporting Information. The desired microﬂuidic conﬁguration
was patterned by UV exposure (UV-KUB2, Kloe, France)
through a low cost emulsion mask, and structures were
subsequently developed using sodium carbonate (Na2CO3) 1%
and rinsed by an aqueous solution of magnesium sulfate
(MgSO4) 0.5%. In addition, the dry ﬁlm structures were
silanized to gain hydrophobic surface properties before a
PDMS replica was obtained from the dry ﬁlm structures to be
used as a master mold. Subsequently UV-curable adhesive
NOA 81 (Norland Products Inc., USA) was used to fabricate
microﬂuidic platforms by cast molding using the PDMS master
mold as described elsewhere.22 This material was selected for
its low cost, chemical resistance, adjustable wetting properties23
and high pressure resistance.24 Fabrication details are given in
the Supporting Information.
Chemical Surface Modiﬁcation. Microﬂuidic channels were
hydrophobized by means of a silanization to ensure a stable and
reproducible droplet generation. The silanization process was
performed using 1H,1H,2H,2H-perﬂuorodecyltrichlosilane
(FDTS, Sigma-Aldrich) in a glovebox (Erlab, U.S.A.) initially
ﬁlled with nitrogen. The NOA 81 microﬂuidic channels were
ﬁrst carefully cleaned with ethanol and 2,2,4-trimethylpentane
at a ﬂow rate of 200 μL/h for 30 min. The channels were then
ﬁlled with a mixture of 1.5% v/v FDTS and 2,2,4-
trimethylpentane. After 15 min of incubation, excess of FDTS
was removed by ﬂushing the channel with isooctane and
isopropanol, respectively, 20 min each. The device was dried
overnight at a temperature of 65 °C.
Connection to the SAXS Sample Holder, Device Oper-
ation. Links between the microﬂuidic chip and the SAXS
sample holder were made by connecting fused silica capillaries
(ID 280 μm, OD 360 μm, Postnova analytics) directly to the
exit of the microﬂuidic platform to the quartz capillary (OD
300 μm, wall thickness 10 μm) of the sample holder. The
connection was ensured by a zero dead volume connector from
IDEX (P-720). The quartz capillary was hermetically sealed
into the sample holder in order to keep vacuum around it for
obtaining high-quality SAXS data. With this setup, SAXS
experiments were performed at a residual pressure of ∼10−2
mbar.
Reagent ﬂow rates pumped into the microﬂuidic platform
were controlled by high precision syringe pumps (neMESYS
Cetoni, Germany), coupled to 1 mL syringes (Hamilton,
U.S.A.).
Proteins Preparation. Two diﬀerent proteins were used in
this study, rasburicase (Sanoﬁ) and lysozyme (purchased from
Sigma-Aldrich, dialyzed lyophilized 629710)). In the case of
lysozyme, all experiments were conducted in sodium acetate
buﬀer (50 mM sodium acetate, pH 4.4) prepared with distilled
water from a Milli-Q water puriﬁcation system (Millipore,
Billerica, MO). Prior use, the lysozyme solutions were prepared
according to Parmar,25 in order to remove any unwanted
aggregates present in most of the commercially available
lysozyme. Details on the preparation procedure are given in the
Supporting Information.
In the case of rasburicase, all the experiments were
performed using 50 mM Tris buﬀer at pH 8.
Lysozyme and rasburicase were dissolved into the corre-
sponding buﬀer to the required concentration after ﬁltering
through a 0.22-μm sterile ﬁlter (Millipore). The proteins
concentrations were determined by absorbance measurements
using the extinction coeﬃcient of 2.64 mL mg−1 cm−1 at 280
nm for lysozyme and of 2.2 (±0.1) ml mg−1 cm−1 for
rasburicase.
Small Angle X-ray Scattering Experiments. Synchro-
tron SAXS measurements were performed on the beamline
BM29 at the European Synchrotron Radiation Facility (ESRF)
in Grenoble, France.26 The two-dimensional SAXS patterns
were recorded with a 1 M Pilatus detector. The experimental X-
ray wavelength and the sample-to-detector distance were
0.0991 nm and 2.87 m, respectively, covering a range of 0.03−
4.5 nm−1 for the scattering vector q = 4π sin θ/λ. The beam
cross-section at sample plane deﬁned by slits was 90 μm
(vertically) × 165 μm (horizontally). The sample holder can be
translated with respect to the X-ray beam by a few millimeters
with a precision of ten microns.
Using our microﬂuidic platform, water-in-oil droplets of
protein, buﬀer and crystallization agent were formed and
carried by an immiscible ﬂuorous oil (Krytox GPL100,
DuPont) containing ﬂuorinated surfactant in order to stabilize
the droplets interface. The selection of this continuous phase
was made considering a good resistance to X-ray radiation
damage, an optimal viscosity and immiscibility with the
aqueous phase.
Preliminary experiments were performed with diﬀerent oils
and oil purities. Several silicone (Rhodorsil 47) and ﬂuorous
oils (perﬂuorodecalin (sigma Aldrich), FC 70 (3M), FC 40
(3M), and Krytox GPL 100 (Dupont)) have been tested, and it
has been found that only Krytox GPL 100 can handle highly
powerful X-ray radiation generated from a synchrotron source
without any signiﬁcant radiation damages.
Two diﬀerent ﬂuorosurfactants were used: 1H,1H,2H,2H-
perﬂuorooctanol (PFO − C8H5F13O) (Sigma) and a triblock
copolymer (PFPE−PEG-PFPE) synthesized as described
elsewhere19 or purchased from Ranbiotechnology (U.S.A.).
Both surfactants were dissolved at a concentration of 2% w/w
in the continuous phase to make stable droplets. Microﬂuidic
design, microﬂuidic platform, and connection to the BM29
sample holder are depicted in Figure 1.
In order to gather high quality data (by acquiring only the
SAXS data inside the droplets) and to reduce radiation damage
of the oil and the protein, the X-ray beam, the CCD detector,
and the droplets were synchronized. The synchronization is
based on real time image processing (developed in OpenCV
and Matlab). Brieﬂy, the template matching algorithm detects
the front of the droplet ﬂowing in the capillary and sends a
TTL signal to the beamline shutter and the Pilatus camera to
trigger the acquisition. Depending on the size and the speed of
the droplets, this results in the acquisition of one to three SAXS
signals per droplet. In addition, this approach allows us to avoid
shooting droplet interfaces which produces a huge SAXS signal
at very low angles and can cause miss interpretations of the
data.
■ RESULTS AND DISCUSSION
Validation of the Experimental Setup: Protein Form
Factor. Prior to any SAXS experiment, it was necessary to ﬁnd
a suitable surfactanct allowing a compromise concerning the
stable operation of the microﬂuidic platform and ensuring that
proteins in solution are not interacting with the interface
between oil and water. To this end, an active and native
tetrameric form of rasburicase was used to optimize the setup,
due to its high sensitivity to denaturation/dissociation. Initially,
droplets containing 20 mg/mL of rasburicase in Tris buﬀer at
pH = 8.0 were generated using 2 wt % perﬂuoorooctanol
(PFO) as surfactant in Krytox GPL100 oil. In order to show to
what extent the selection of an appropriate surfactant is
important, the corresponding SAXS curves of rasburicase
describing the scattered intensity as a function of the scattering
vector are presented in Figure 2. The black dots correspond to
the SAXS experimental results whereas the green and red
curves are the simulated scattered intensities obtained from
atomic coordinates using CRYSOL20 software for the tetramer
and the dimer of rasburicase (obtained from the Protein Data
Bank structure ﬁle 1r51) respectively. The blue curve calculated
from the experimental data using OLIGOMER27 software
represents the best ﬁt of experimental result and indicates that
the protein solution in the droplet is a mixture of 58% tetramer
and 42% dimer.
Under these experimental conditions (oil and surfactant),
rasburicase in solution behaves as a mixture of the native
tetrameric form and the incompletely dissociated dimeric form.
This suggests that the surfactant at the interface, in particular
the surfactant polar heads in the aqueous droplet may interact
with tetramers of rasburicase, dissociating tetramers into
dimers.
To avoid any denaturation of proteins at the interface, a
biocompatible triblock copolymer PFPE−PEG-PFPE surfactant
described elsewhere27 was used at an optimized concentration
of 2 wt % in Krytox GPL100. From the work of Holtze et al.,27
this surfactant is known to act as a protectant of protein
adsorption at the oil−water interface. The results of SAXS
experiments on rasburicase droplets equivalent to the previous
experiments are presented in Figure 2. It is worth noting that,
using this surfactant, the curve for the native rasburicase
tetramer obtained by CRYSOL software perfectly ﬁts the SAXS
experimental data and is in good agreement with the published
data of raburicase form factor28 proving that the protein is not
denaturated/dissociated. This result shows that the combina-
Figure 1. Design of microﬂuidic chip conﬁguration (top). Picture of a
microﬂuidic chip mounted on a microscope (middle). Connection
between microﬂuidic chip and sample holder (bottom).
tion of PFPE−PEG-PFPE surfactant and Krytox GPL100
avoids denaturation of proteins and the protein has the same
structure in droplets as in classical capillaries. Similar results
have been obtained for less sensitive proteins like lysozyme,
bovine serum albumin, and glucose isomerase. This combina-
tion would therefore allow the study of macromolecular
interactions in solution (structure factor) and form factor of
proteins in droplets having equivalent experimental conditions
to those SAXS experiments in microvolumes.29
Study of Weak Interactions for Crystallization
Conditions. Once the experimental setup was validated, the
variation of weak interactions between proteins in solution was
studied using lysozyme as a model protein. The experiment was
carried out using lysozyme at a stock concentration of 130 mg/
mL in sodium acetate buﬀer at pH 4.4. NaCl was used as the
crystallizing agent as previously described,5 at a stock
concentration of 2 M, and the continuous phase was formulated
according to the previous validation experiment thus ensuring
no interaction between protein and droplet interfaces. Figure 3
shows a picture of the microﬂuidic platform in operation. The
continuous phase (oil) is injected in the left channel, salt in the
top left channel, buﬀer in the top middle channel, and protein
in the top right channel, respectively.
An important advantage of this microﬂuidic setup is that
crystallization agent concentrations can be screened just by
simply altering the ﬂow rates of the incoming solutions. The
diﬀerent experimental conditions applied are presented in
Table S2 of the Supporting Information. The SAXS curves of
lysozyme at diﬀerent NaCl concentrations are presented in
Figure 4.
The scattered intensity of a solution of macromolecules
under weak interactions can be written as
= = ×I c q I c q S c q( , ) ( 0, ) ( , )FF (1)
where IFF is the form factor, which represents the ideality of the
solution and it depends only on the macromolecule itself
(shape, size, ...), S represents the structure factor of the
macromolecule solution and depends on weak interactions
between macromolecules in solution (hard sphere/electrostatic
interactions, van der Waals attraction, ...). These interactions
are characterized by a second virial coeﬃcient A2, which
corresponds to variations of S(c,q = 0) as a function of
macromolecule concentration:31,32
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where M is the molecular weight of the macromolecules and c is
their concentration. S(c,q = 0) < 1 value (A2 > 0) describes
macromolecules under repulsive interactions. Respectively, if
S(c,q = 0) > 1 (A2 < 0), it describes macromolecular attractive
interactions.
For a given SAXS curve with ﬁxed protein and salt
concentration, the forward intensity at zero angle I(c,q = 0)
and the form factor IFF(c = 0,q = 0) from eq 1 can be calculated.
I(c,q = 0) is obtained by means of a Guinier plot, ln I(c,q) =
f(q2), when the scattering vector tends to zero. The Guinier
approximation is
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RG being the radius of gyration, this approximation is only valid
at low scattering angles so that qRG < 1. By plotting ln I = f(q
2)
in the Guinier range, the forward intensity I(c,q = 0) can be
estimated when the scattering vector tends to zero. As an
example, a Guinier plot for lysozyme at 52 mg/mL
concentration and 300 mM NaCl is shown in Figure 5.
Analogously, the form factor can be obtained by plotting the
forward intensity at zero angle, I(c,q = 0), as a function of the
protein concentration and extrapolating to zero at each salt
concentration (Figure 5). Thus, the structure factor at zero-q
can be calculated from eq 1:
= = =
= =
S c q
I c q
I c q
( , 0)
( , 0)
( 0, 0)FF (4)
Figure 2. SAXS curves of rasburicase with PFO surfactant (top) SAXS
curve of rasburicase with PFPE−PEG-PFPE surfactant (bottom).
Blacks dots are experimental data, green and red curves are scattering
curves from atomic coordinates for tetramers (1r51) and dimers,
respectively, and the blue curve is the best ﬁt for a mixture of dimers
and tetramers.
Figure 3. Screen snapshot of droplet generation recorded during
crystallization experiments for interaction screening. Left channel
contains the oil with surfactant, top left channel the salt, top middle
channel the buﬀer, and top right channel the protein.
A2 can therefore be obtained from the experimental SAXS
data for the diﬀerent salt and protein concentrations. The
obtained A2 values are summarized in Figure 6. It can be
noticed that, without salt, the protein is in a repulsive state due
to strong electrostatic repulsion caused by the positive net
charge of lysozyme at pH 4.4. When a small quantity of salt is
added into droplets, the charges of lysozyme are partially
screened and the repulsion due to electrostatic forces is
reduced, leading to a decrease of the second virial coeﬃcient.
When there is enough salt to screen all the charges of lysozyme,
there is no more repulsion between proteins, the interactions
become attractive. This can be observed at salt concentrations
above 180 mM where A2 becomes negative, pointing out an
inﬂection point on macromolecular behavior that would lead to
macromolecule aggregation and eventually to crystallization.
These observations are in good agreement with previous
ﬁndings obtained in microbatch volumes30 therefore validating
the microﬂuidic approach, by which good quality data has been
obtained using a very small amount of proteins. In total only 12
mg of lysozyme has been used in this study. It is worth noting
that all the results were obtained in two diﬀerent synchrotron
runs with diﬀerent microﬂuidic chips and diﬀerent stock
solutions. All the obtained results were in good agreement with
each other, proving the repeatability and the robustness of the
approach.
Figure 4. SAXS curves of lysozyme with increasing NaCl
concentration from 0 to 400 mM. Lysozyme concentrations, top:
21.7 mg/mL; middle: 52 mg/mL; and bottom: 86.7 mg/mL.
Figure 5. Guinier plot for lysozyme 52 mg/mL and salt 300 mM
(top). Scattered intensity at zero angle as a function of lysozyme
concentration at diﬀerent salt concentrations (bottom).
Figure 6. Variations of the second virial coeﬃcient for lysozyme as a
function of salt concentration.
■ CONCLUSIONS
The combination of SAXS and high throughput, droplet based
microﬂuidics is here proposed as a powerful tool to investigate
macromolecular interactions, directly related to protein
solubility. The microﬂuidic droplet ﬂow was synchronized
with synchrotron radiation SAXS measurements to probe
protein interactions while minimizing radiation damage. To this
end, the experimental setup was tested and optimized with
rasburicase (known to be very sensitive to denaturation),
proving the structural stability of the protein in the droplets and
the absence of radiation damage, underlining the fact that the
protein in droplets has the same behavior as in a standard
solution. Subsequently weak interaction variations as a function
of protein saturation were studied for the model protein
lysozime. The second virial coeﬃcients (A2) were determined
from the X-ray structure factors extrapolated to the origin. The
results show that without salt, the lysozyme solution is in the
repulsive regime, and it changes to attractive regime when the
salt concentration increases. By adding more salt, charges of
lysozyme could be screened and the interaction between
proteins becomes attractive. A2 obtained values were found to
be in good agreement with data previously reported in the
literature but using only a few milligrams of protein.
This versatile microﬂuidic tool could be applied to numerous
systems in a standardized way. Using droplet microﬂuidics
coupled with SAXS, structural studies of macromolecules in
solution can be accomplished with signiﬁcantly reduced time
and sample quantity.
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Bauch, S.; Herrmann, H.; Pfohl, T.; Köster, S. Lab Chip 2011, 11 (4),
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